Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lamotrigine-induced lupus.

P Sarzi-Puttini1, B Panni, M Cazzola

  • 1Rheumatology Unit, Department of Internal Medicine, University Hospital L Sacco, Milan, Italy. sarzi@tiscalinet.it

Lupus
|October 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy.

Respiratory medicine·2023
Same author

The mechanical and chemical stability of the interfaces in bioactive materials: The substrate-bioactive surface layer and hydroxyapatite-bioactive surface layer interfaces.

Materials science & engineering. C, Materials for biological applications·2020
Same author

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

Leukemia·2020
Same author

A continuous-time Markov model approach for modeling myelodysplastic syndromes progression from cross-sectional data.

Journal of biomedical informatics·2020
Same author

Pharmacology and Therapeutics of Bronchodilators Revisited.

Pharmacological reviews·2019
Same author

Bioactive materials: In vitro investigation of different mechanisms of hydroxyapatite precipitation.

Acta biomaterialia·2019
Same journal

Association of systemic lupus erythematosus with 90-day readmission following heart failure hospitalization: A national readmission database (NRD) analysis, 2016-2017.

Lupus·2026
Same journal

Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus.

Lupus·2026
Same journal

Giant cell myocarditis in an 18-year-old patient with new-onset systemic lupus erythematosus: A fatal case of rapidly progressing heart failure.

Lupus·2026
Same journal

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research.

Lupus·2026
Same journal

T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus.

Lupus·2026
Same journal

Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis.

Lupus·2026
See all related articles

This case report details a woman who developed systemic lupus erythematosus (SLE) symptoms, including rash and joint pain, after taking lamotrigine for epilepsy. Symptoms resolved after discontinuing the medication, suggesting a drug-induced lupus.

Area of Science:

  • Rheumatology
  • Neurology
  • Clinical Pharmacology

Background:

  • Lamotrigine is an antiepileptic drug commonly prescribed for seizure disorders.
  • Drug-induced systemic lupus erythematosus (DI-SLE) is a recognized adverse effect of various medications.

Observation:

  • A 57-year-old female patient on long-term lamotrigine therapy presented with arthralgias, erythematosus skin rash, myalgias, and Raynaud's phenomenon.
  • Laboratory findings included positive antinuclear antibodies (ANA) and anti-Ro/SSA antibodies, with negative rheumatoid factor, normal complement, LAC, and anticardiolipin antibodies.

Findings:

  • A diagnosis of drug-related lupus was established.
  • Discontinuation of lamotrigine led to symptom resolution and normalization of ANA and anti-Ro/SSA antibody titers.

Related Experiment Videos

  • This represents the first reported case associating lamotrigine with the onset of systemic lupus erythematosus (SLE).

    • Implications:

    • This case highlights the importance of considering drug-induced lupus in patients presenting with lupus-like symptoms while on lamotrigine.
    • Physicians should be vigilant for potential autoimmune side effects of lamotrigine.
    • Further investigation may be warranted to understand the specific mechanisms linking lamotrigine to SLE development.